New Cholesterol Guidelines Could Put 21 Million More Americans on Statins — Here Is What That Means for Black and Low-Income Communities

A new study published July 20, 2026 in the journal JAMA found that updated cholesterol treatment guidelines from the American Heart Association (AHA) and the American College of Cardiology (ACC) could make an estimated 21.5 million additional Americans eligible for statin therapy — bringing the total to roughly 87.5 million people, or more than half of all adults ages 30 to 79.

That is a headline-grabbing number. But for Black Americans and low-income communities, the story behind that number is more complicated — and more urgent — than the news cycle suggests.

The new guidelines expand who qualifies for statins in four key ways:

1. Wider age range. The previous guidelines focused on adults ages 40–75. The new recommendations extend cardiovascular risk assessment to adults ages 30–79.
2. Lower risk thresholds. Someone is now considered at "high risk" with a 10% chance of a cardiovascular event over 10 years (down from higher prior thresholds), "intermediate risk" at 5%, and "borderline risk" at 3%.
3. Greater weight on certain conditions. Adults ages 40–75 with advanced chronic kidney disease or HIV may now qualify for statins.
4. Long-term risk counts. A person with a low 10-year risk may still be recommended a statin if their estimated 30-year risk is at least 10%.

The goal, according to the guidelines, is to identify people who could benefit from cholesterol management earlier — before a first heart attack or stroke occurs.

Cardiovascular disease is the leading cause of death in the United States — and Black Americans bear a disproportionate share of that burden.

• Black adults are 30% more likely to die from heart disease than white adults.
• Black Americans develop high blood pressure earlier in life and at higher rates.
• Black women are significantly more likely to be undertreated for cardiovascular risk factors compared to white women with identical clinical profiles.
• Structural barriers — including lack of insurance, limited access to primary care, and provider bias — mean that many Black patients never receive the preventive care that could catch these risks early.

The expansion of statin eligibility to younger adults (starting at age 30) is particularly significant here. Cardiovascular risk in Black communities often begins accumulating earlier due to the compounding effects of chronic stress, environmental exposures, food insecurity, and limited healthcare access. Catching that risk at 32 instead of 45 could be lifesaving.

But eligibility on paper means nothing without access in practice.

Being newly "eligible" for a statin does not mean you will get one — or that you should automatically want one. Here is what the guidelines cannot address on their own:

No primary care provider. Statins require a prescription, a lipid panel, and ongoing monitoring. Millions of Black and low-income Americans do not have a regular doctor. Without a care relationship, eligibility is irrelevant.

Cost barriers. While many generic statins are inexpensive, the full picture — office visits, lab work, follow-up appointments — adds up fast for people without insurance or with high-deductible plans.

Provider bias. Research consistently shows that Black patients are less likely to be offered preventive medications, less likely to have their pain taken seriously, and more likely to have their concerns dismissed. A guideline change does not automatically change the behavior of individual providers.

Distrust rooted in history. Black communities have legitimate, historically grounded reasons to approach medical recommendations with caution. The Tuskegee syphilis study, forced sterilizations, and decades of experimentation without consent are not ancient history — they are living memory for many families. That distrust does not disappear because a new guideline was published.

Medication side effects and long-term unknowns. Statins can cause muscle pain and modestly increase the risk of developing diabetes — a condition that already disproportionately affects Black Americans. For younger, lower-risk individuals who may take a statin for decades, these tradeoffs deserve honest, individualized conversation — not a one-size-fits-all prescription.

Whether you are newly eligible under these guidelines or have been managing cholesterol for years, here is how to show up prepared and empowered at your next appointment:

1. Know your numbers before you go. Ask for a lipid panel if you have not had one recently. You want to know your total cholesterol, LDL ("bad" cholesterol), HDL ("good" cholesterol), and triglycerides. Also know your blood pressure, whether you have diabetes, and any family history of heart disease.

2. Ask your provider to run your risk score. The AHA's PREVENT calculator uses your numbers to estimate your 10-year and 30-year cardiovascular risk. Ask your provider to walk through this with you — not just hand you a prescription.

3. Ask the right questions — not just "should I take this?"

• What specific factor makes me eligible for a statin?
• What is my actual 10-year and 30-year risk of a heart attack or stroke?
• How much would a statin reduce that risk for someone with my profile?
• What lifestyle changes could I try first, or alongside medication?
• How will we monitor my cholesterol and any side effects over time?

4. Do not let a rushed appointment make the decision for you. If your provider recommends a statin but cannot answer these questions clearly, it is okay to say: "I want to understand this better before I decide. Can we schedule a follow-up, or can you point me to resources?"

5. Bring someone with you. A trusted family member or friend can help you remember what was said, ask follow-up questions, and advocate if you feel dismissed.

6. Lifestyle changes are not optional — they are foundational. The guidelines are clear: statins work alongside lifestyle changes, not instead of them. A heart-healthy diet rich in vegetables, fruits, whole grains, legumes, and fish — combined with regular physical activity, not smoking, and managing blood pressure and diabetes — reduces cardiovascular risk for everyone, regardless of whether medication is part of the picture.

At DaisyMe Foundation, we believe that a guideline change is only meaningful if the communities most affected by heart disease can actually access and understand it.

Our Care Navigation program connects community members in Frisco, TX and beyond with trained health advocates who can help you:

• Understand what new guidelines like these mean for your specific situation
• Prepare for doctor's appointments with the right questions
• Navigate insurance, find low-cost labs, and identify community health resources
• Advocate for yourself when you feel dismissed or rushed

Our Community Health Education workshops — including our Patient Self-Advocacy & Provider Bias track — give you the tools to walk into any medical appointment as an informed, empowered participant in your own care.

All of our services are 100% free. No insurance required. No referral needed.

The new cholesterol guidelines represent a genuine shift toward earlier, more proactive cardiovascular care. For Black and low-income communities who carry the heaviest burden of heart disease, that shift has real potential — but only if it is paired with equitable access, honest provider conversations, and community-level support.

Eligibility is not destiny. And a prescription is not the same as care.

If you have questions about what these guidelines mean for you, or if you want help preparing for a conversation with your doctor, DaisyMe Foundation is here. Reach out through our website, attend one of our free workshops, or connect with a care navigator today.

Your heart health is worth fighting for — and you do not have to fight alone.

Source: Hetter, Katia. "Considering statins? New US cholesterol guidelines may change your decision." CNN/Yahoo Health, July 27, 2026. Original study published in JAMA, July 20, 2026.

DaisyMe Foundation does not provide medical advice. This article is for educational and advocacy purposes only. Please consult a qualified healthcare provider before making any decisions about medication or treatment.